Literature DB >> 10439210

RSH (so-called Smith-Lemli-Opitz) syndrome.

J M Opitz1.   

Abstract

Now known as a Garrodian inborn error caused by the homozygous state of many different autosomal recessive mutations of the 7-dehydrocholesterol reductase gene leading to deficient conversion of 7-dehydrocholesterol to cholesterol, the RSH (so-called Smith-Lemli-Opitz) syndrome has become a paradigmatic metabolic malformation syndrome in a pathway that also involves cause and pathogenesis of desmosterolosis, two forms of the Conradi-Hünermann-Happle type chondodysplasia punctata and its mouse homologs, and the Greenberg "moth-eaten" skeletal dysplasia and the CHILD syndrome. Many other defects in this pathway remain to be discovered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439210     DOI: 10.1097/00008480-199908000-00015

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  11 in total

1.  Smith-Lemli-Opitz-syndrome.

Authors:  Rachana Gedam; Ira Shah; Uma Ali; Alpana Ohri
Journal:  Indian J Hum Genet       Date:  2012-05

2.  Desmosterolosis presenting with multiple congenital anomalies.

Authors:  Mersedeh Rohanizadegan; Stephanie Sacharow
Journal:  Eur J Med Genet       Date:  2017-11-23       Impact factor: 2.708

3.  Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin.

Authors:  Luke J Engelking; Bret M Evers; James A Richardson; Joseph L Goldstein; Michael S Brown; Guosheng Liang
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

4.  Increasing cholesterol synthesis in 7-dehydrosterol reductase (DHCR7) deficient mouse models through gene transfer.

Authors:  Xavier Matabosch; Lee Ying; Montserrat Serra; Christopher A Wassif; Forbes D Porter; Cedric Shackleton; Gordon Watson
Journal:  J Steroid Biochem Mol Biol       Date:  2010-08-26       Impact factor: 4.292

5.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

6.  Challenging behavior in Smith-Lemli-Opitz syndrome: initial test of biobehavioral influences.

Authors:  Kurt A Freeman; Rose Eagle; Louise S Merkens; Darryn Sikora; Kersti Pettit-Kekel; Mina Nguyen-Driver; Robert D Steiner
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600

7.  Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome.

Authors:  Anna V Oláh; Gabriella P Szabó; József Varga; Lídia Balogh; Györgyi Csábi; Violetta Csákváry; Wolfgang Erwa; István Balogh
Journal:  Eur J Pediatr       Date:  2013-01-15       Impact factor: 3.183

Review 8.  Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.

Authors:  Melissa D Svoboda; Jill M Christie; Yasemen Eroglu; Kurt A Freeman; Robert D Steiner
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-05       Impact factor: 3.908

9.  Hypothesis: the role of sterols in autism spectrum disorder.

Authors:  Ryan W Y Lee; Elaine Tierney
Journal:  Autism Res Treat       Date:  2011-04-27

10.  Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase.

Authors:  Nicola Brunetti-Pierri; Gaetano Corso; Massimiliano Rossi; Paola Ferrari; Fiorella Balli; Francesco Rivasi; Ida Annunziata; Andrea Ballabio; Antonio Dello Russo; Generoso Andria; Giancarlo Parenti
Journal:  Am J Hum Genet       Date:  2002-08-20       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.